The use of TgAbs as a marker in differentiated thyroid cancer after ablation theraphy

Basit Öğe Kaydı
dc.contributor.authorYazici, B.
dc.contributor.authorAkgun, A.
dc.contributor.authorErdim, O.
dc.contributor.authorDuygun, U.
dc.contributor.authorOzkilic, H.
dc.date.accessioned2019-10-27T19:17:28Z
dc.date.available2019-10-27T19:17:28Z
dc.date.issued2006
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS330en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS330en_US
dc.identifier.urihttps://hdl.handle.net/11454/38388
dc.identifier.volume33en_US
dc.identifier.wosWOS:000202967401199en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imagingen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe use of TgAbs as a marker in differentiated thyroid cancer after ablation theraphyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu